Cargando…
Impact on Malaria Parasite Multiplication Rates in Infected Volunteers of the Protein-in-Adjuvant Vaccine AMA1-C1/Alhydrogel+CPG 7909
BACKGROUND: Inhibition of parasite growth is a major objective of blood-stage malaria vaccines. The in vitro assay of parasite growth inhibitory activity (GIA) is widely used as a surrogate marker for malaria vaccine efficacy in the down-selection of candidate blood-stage vaccines. Here we report th...
Autores principales: | Duncan, Christopher J. A., Sheehy, Susanne H., Ewer, Katie J., Douglas, Alexander D., Collins, Katharine A., Halstead, Fenella D., Elias, Sean C., Lillie, Patrick J., Rausch, Kelly, Aebig, Joan, Miura, Kazutoyo, Edwards, Nick J., Poulton, Ian D., Hunt-Cooke, Angela, Porter, David W., Thompson, Fiona M., Rowland, Ros, Draper, Simon J., Gilbert, Sarah C., Fay, Michael P., Long, Carole A., Zhu, Daming, Wu, Yimin, Martin, Laura B., Anderson, Charles F., Lawrie, Alison M., Hill, Adrian V. S., Ellis, Ruth D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142129/ https://www.ncbi.nlm.nih.gov/pubmed/21799809 http://dx.doi.org/10.1371/journal.pone.0022271 |
Ejemplares similares
-
Phase 1 Trial of AMA1-C1/Alhydrogel plus CPG 7909: An Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria
por: Mullen, Gregory E. D., et al.
Publicado: (2008) -
Phase 1 Study in Malaria Naïve Adults of BSAM2/Alhydrogel®+CPG 7909, a Blood Stage Vaccine against P. falciparum Malaria
por: Ellis, Ruth D., et al.
Publicado: (2012) -
Phase 1 Trial of the Plasmodium falciparum Blood Stage Vaccine MSP1(42)-C1/Alhydrogel with and without CPG 7909 in Malaria Naïve Adults
por: Ellis, Ruth D., et al.
Publicado: (2010) -
Phase Ia Clinical Evaluation of the Safety and Immunogenicity of the Plasmodium falciparum Blood-Stage Antigen AMA1 in ChAd63 and MVA Vaccine Vectors
por: Sheehy, Susanne H., et al.
Publicado: (2012) -
Safety and Immunogenicity of Pfs25-EPA/Alhydrogel(®), a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults
por: Talaat, Kawsar R., et al.
Publicado: (2016)